Biostem (Biostem) - ICO Details

Biostem - Biostem ICO details,price, stage, bonus, team.
Biostem (Biostem) Initial Coin Offering Logo
HeadlineHighly sophisticated biochemical cell technology
CategoryDrugs & Healthcare
Starting date04/01/2019
Ending date05/30/2019
WebsiteView Website
WhitepaperView Whitepaper

Biostem ICO Summary

Biostem is bringing blockchain solution in the Drugs & Healthcare industry.

Their initial coin offering will be held from April 1, 2019 and investors will be able to buy it until May 30, 2019.

A total of 0 Biostem will be created and 60,000,000 will be available during the coin offering.

Biostem sale will be considered successful if their softcap of 0(USD) is reached. Please keep in mind that the sale could end before May 30, 2019 if the hardcap of 1,000,000(USD) is reached.

During Biostem ICO, investors will be able to buy Biostem at 0.8 USD per Coin/Token.

Get all the details about Biostem below and on Biostem Official ICO website

Biostem Project Info

Highly sophisticated biochemical cell technology combined with blockchain technology.

Biostem is a cutting edge technology that aims to revolutionize the modern day medical and biotech industry by providing a decentralized platform which can be used for transactional activities, tracking purposes, Contract manufacturing and outsourcing, Monitoring and recording patient’s data, streamlining medical device lifecycles & healthcare, contract manufacturing and Clinical trial management. In doing so, we also aim ensure that modern day Biotech products are readily available for everyone—not only the rich— at cheaper rates.


Coin SymbolBiostem
Total Coins0
Working Product?

Biostem ICO Details

Biostem ICO Details
Geo RestrictionNone
Currency AcceptedETH
Total CoinsUnknown
Coins for Sale60,000,000
Private-Sale/Pre-Mined CoinsUnknown
Coins SoldUnknown
Coin Price0.8 USD
Softcap Reached
Confirmed Exchange
Unsold Coins Goes to

Biostem Stage Details


Start date04/01/2019
End date05/30/2019
Token for sale60,000,000
Token Price0.8 USD

Biostem Team Info

Core Team

Kelson Beck

Chief Marketing Officer

Dawson Roland

Chief Technology Officer

Catherine Harrison

Chief Operating Officer

Matthew Hudson

Chief Financial Officer

Allyson Brock

Human Resource Director

Jozie Ayaz Khan

Business Development Director

Brayden Parker

Biotech Research Consultant

Sanjay Uttam Kharade

Business Consultant - Asia

Biostem Discussion

Please Login to join the discussion
Notify of
Featured ICOs
There are No Featured ICOs right now
Trend Surfers
Recently Viewed ICO

Filter Info ICL
Join our Newsletter


Don't miss out!

Get discounts on ICOs & Blockchain products + Receive the latest News, Updates & PR from ICL.